首页|噻托溴铵联合舒利迭对老年中重度COPD患者的疗效及生存质量研究

噻托溴铵联合舒利迭对老年中重度COPD患者的疗效及生存质量研究

扫码查看
目的 研究观察噻托溴铵联合舒利迭治疗老年中重度慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)的临床疗效及对患者生存质量的影响.方法 选取广东省第二人民医院呼吸内科2014年1月~2016年1月收治的中重度COPD稳定期患者114例,按随机数字表法分为观察组和对照组,每组57例.对照组患者给予舒利迭治疗,观察组患者采用噻托溴铵联合舒利迭治疗,对比2组患者治疗效果和生活质量.结果 治疗前,2组患者各项肺功能指标、MRC评分、6MWT及WHOQOL-100各项评分比较差异均无统计学意义;治疗后观察组患者FEV1/FVC、FEV1%显著于对照组,差异具有统计学意义(P<0.05);观察组患者呼吸困难程度评分(MRC)及6分钟步行试验(6MWT)明显优于对照组,差异具有统计学意义(P<0.05);观察组患者各项生存质量评分(WHOQOL-100)显著高于对照组,数据比较差异具有统计学意义(P<0.05).结论 噻托溴铵联合舒利迭治疗老年中重度COPD疗效确切,可有效改善患者肺功能水平,提高患者生存质量.
Study on the efficacy and quality of life of tiotropium combined with sulpiride in elderly patients with moderate to severe COPD
Objective To observe the effect of tiotropium combined Seretide in the treatment of elderly patients with moderate to severe COPD clinical curative effect and the influence on the quality of life of patients.Methods114 cases of moderate or severe COPD in our hospital from January 2014 to January 2016,were randomly divided into observation group and control group, 57 cases in each group.The control group was treated with Seretide treatment, the observation group were treated by tiotropium combined with Seretide treatment, compared two groups of patients with curative effect and quality of life.ResultsBefore treatment, there were no significant differences in lung function index, MRC score, 6MWT and WHOQOL-100 scores between the two groups;After treatment, FEV1/FVC and FEV1% in the observation group were significantly higher than in the control group, and the difference was statistically significant (P<0.05);the dyspnea severity score (MRC) and six minute walk test (6MWT) in the observation group were significantly better than those in the control group, and the differences were statistically significant (P<0.05);the quality of life score (WHOQOL-100) in the observation group was significantly higher than in the control group, the difference was statistically significant (P<0.05).ConclusionTiotropium bromide combined with nimesulide in the treatment of elderly patients with moderate or severe COPD is effective, and can effectively improve the level of pulmonary function, improve the quality of life of patients.

moderate to severe COPDelderly patientstiotropiumseretidecurative effectquality of life

颜文森、李斌、王燕、江小运、王钧

展开 >

广东省第二人民医院呼吸内科,广东广州510317

中重度COPD 老年患者 噻托溴铵 舒利迭 疗效 生存质量

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.(5)
  • 8
  • 9